4.7 Article

Pharmacogenetic Sex-Specific Effects of Methotrexate Response in Patients with Rheumatoid Arthritis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Can we predict unresponsiveness to methotrexate in rheumatoid arthritis? A pharmacogenetic study

Meltem Alkan Melikoglu et al.

Summary: This study found heterozygosity in the C3435T SNP of the ABCB1 gene (multidrug resistant 1 gene) in almost all RA patients who were non-responders to MTX. This result may help predict unresponsiveness to MTX in RA and guide the development of individualized treatment strategies based on the pharmacogenetic characteristics of MTX for optimal treatment outcomes.

INFLAMMOPHARMACOLOGY (2022)

Article Multidisciplinary Sciences

Osteoprotegerin and MTHFR gene variations in rheumatoid arthritis: association with disease susceptibility and markers of subclinical atherosclerosis

Aikaterini Arida et al.

Summary: This study found that genetic variations in the OPG and MTHFR genes are associated with susceptibility to rheumatoid arthritis (RA) and subclinical atherosclerosis linked to RA.

SCIENTIFIC REPORTS (2022)

Article Multidisciplinary Sciences

Genetic variations in methotrexate metabolic pathway genes influence methotrexate responses in rheumatoid arthritis patients in Malaysia

Hong Xi Sha et al.

Summary: This study investigated the genetic risk factors that affect the therapeutic outcomes in Malaysian rheumatoid arthritis (RA) patients treated with methotrexate (MTX). The results showed that none of the single nucleotide polymorphisms (SNPs) had an influence on MTX efficacy or toxicity in the overall population. However, two SNPs were significantly associated with MTX adequate response in RA patients with Malay ancestry. Further evaluation is needed to confirm their impact on MTX efficacy using a larger ancestry-specific cohort.

SCIENTIFIC REPORTS (2022)

Review Pharmacology & Pharmacy

The Role of Genetic Polymorphisms in High-Dose Methotrexate Toxicity and Response in Hematological Malignancies: A Systematic Review and Meta-Analysis

Zaiwei Song et al.

Summary: This systematic review investigated the genetic association of gene variants within the HDMTX pathway and their impact on clinical outcomes. Certain SNPs were found to be significantly associated with increased risk of HDMTX toxicity, while others showed a tendency towards decreased toxicity. Additional studies with larger sample sizes are needed to further explore the genetic influences on treatment outcomes.

FRONTIERS IN PHARMACOLOGY (2021)

Editorial Material Pharmacology & Pharmacy

The effects of sex on pharmacogenetically guided drug treatment

Silvia Mezzalira et al.

Summary: Research in sex-related pharmacogenetics helps to explain sex discrepancies in drug response and is essential for personalized medicine.

PHARMACOGENOMICS (2021)

Article Medicine, General & Internal

Genetic Polymorphisms of GGH and ABCC2 Are Associated with Methotrexate Intolerance in Patients with Rheumatoid Arthritis

Alejandro Escudero-Contreras et al.

Summary: This study identified significant associations between the GGH-T401C genotype and MTX intolerance, and the ABCC2-C24T genotype and MTX intolerance. These findings may contribute to the development of new biomarkers and personalized medicine for patients with RA.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Pharmacology & Pharmacy

The evolution in our understanding of the genetics of rheumatoid arthritis and the impact on novel drug discovery

Filip Machaj et al.

EXPERT OPINION ON DRUG DISCOVERY (2020)

Letter Rheumatology

CDAI and DAS28 in the management of rheumatoid arthritis in clinical practice

Satoshi Takanashi et al.

ANNALS OF THE RHEUMATIC DISEASES (2020)

Editorial Material Pharmacology & Pharmacy

Pharmacogenetics of methotrexate response in rheumatoid arthritis: an update

Stephanie F. Ling et al.

PHARMACOGENOMICS (2020)

Article Pharmacology & Pharmacy

MTHFR, TYMS and SLCO1B1 polymorphisms and adverse liver effects of methotrexate in rheumatoid arthritis

Johanna Karlsson Sundbaum et al.

PHARMACOGENOMICS (2020)

Review Biochemistry & Molecular Biology

Using pharmacogenetics to predict methotrexate response in rheumatoid arthritis patients

Bartosz Szostak et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2020)

Review Rheumatology

The genetics of rheumatoid arthritis

Laura E. Dedmon

RHEUMATOLOGY (2020)

Article Medicine, General & Internal

Rheumatoid arthritis

Josef S. Smolen et al.

NATURE REVIEWS DISEASE PRIMERS (2018)

Review Rheumatology

Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges

Josef S. Smolen et al.

NATURE REVIEWS RHEUMATOLOGY (2015)

Article Surgery

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration

Jan P. Vandenbroucke et al.

INTERNATIONAL JOURNAL OF SURGERY (2014)